跳至主要内容
临床试验/CTRI/2024/07/069746
CTRI/2024/07/069746尚未招募3 期

Effectiveness of Gut Microbiome as an add on to T.ESCITALOPRAM ( Anti Depressant ) in Depressive Disorder: A Randomised Double Blinded Prospective Treatment Evaluation Study - NI

SVS Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients who have been diagnosed as moderate or severe depressive disorder according to ICD 10 first episode or multiple episodes.
  • 2.Subjects willing to give consent.

排除标准

  • 1.Patients diagnosed with Mild Depressive Disorder.
  • 2.Patients diagnosed with Bipolar Depression.
  • 3.Patients with a Pre-existing mental illness other than Depressive disorder.
  • 4.Patients who are diagnosed with Thyroid abnormalities.
  • 5.Patients who were diagnosed with Gastrointestinal infections or with inflammatory bowel disease during 4 weeks before inclusion into the study.
  • 6.Patients who have been on Steroids or Antibiotics during 4 weeks before inclusion into the study.

研究者

发起方
SVS Medical College and Hospital

相似试验